SHOULDER INNOVATIONS, INC.
Close on Oct 19, 2026
- Market cap
- $378.43M
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Next report expected Nov 11, 2026, before market open (estimated from past report dates)
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q2 FY2026 Ended Jun 30, 2026 | Aug 6, 2026 | After market close | $17.20M | $-0.49 | – |
| Q1 FY2026 Ended Mar 31, 2026 | May 13, 2026 | After market close | $16.70M | $-0.41 | – |
| Q4 FY2025 Ended Dec 31, 2025 | Mar 10, 2026 | After market close | $14.40M | $-0.38 | – |
| Q3 FY2025 Ended Sep 30, 2025 | Nov 12, 2025 | Before market open | $11.80M | $-0.64 | – |
| Q2 FY2025 Ended Jun 30, 2025 | Sep 9, 2025 | Before market open | $11.00M | $-165.53 | – |
Company guidance
Outlook given with results on Aug 6, 2026, compared with the previous outlook
| Measure | Period | Guidance | vs. prior |
|---|---|---|---|
| net revenue | full year 2026 | $67.00M to $69.00M | Raised |
| growth over full year 2025 net revenue | full year 2026 | 42% to 46% growth | Raised |
Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.
Press releases
Announcements Shoulder Innovations filed with the SEC
Shoulder Innovations Initiates Commercial Launch of the InSet® Go
Regulation FD disclosure · EX-99.1 to Form 8-K
Shoulder Innovations Promotes Jon Osborne to Chief Commercial Officer
Regulation FD disclosure · EX-99.1 to Form 8-K
Shoulder Innovations Reports Second Quarter 2026 Financial Results and Raises Full Year Outlook
Results of operations · EX-99.1 to Form 8-K
Shoulder Innovations Announces Closing of up to $50 Million Credit Facility
Material agreement · Agreement terminated · New financial obligation · Regulation FD disclosure · EX-99.1 to Form 8-K
Shoulder Innovations Reports First Quarter 2026 Financial Results and Raises Full Year Outlook
Results of operations · EX-99.1 to Form 8-K
Shoulder Innovations Initiates Full Commercial Launch of the InSet™ I-135RFX Humeral Stem
Regulation FD disclosure · EX-99.1 to Form 8-K
Shoulder Innovations Reports Fourth Quarter and Full Year 2025 Financial Results
Results of operations · Executive or director change · EX-99.1 to Form 8-K
Shoulder Innovations Appoints MedTech Veteran Drew Hykes to Board of Directors
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Shoulder Innovations Announces Strategic Partnership with INS to Introduce a Robotic Platform for Shoulder Arthroplasty
Regulation FD disclosure · EX-99.1 to Form 8-K
Shoulder Innovations Reports Third Quarter 2025 Financial Results and Increases Full-Year Revenue Guidance
Results of operations · EX-99.1 to Form 8-K
Third Quarter 2025 Earnings Call
Results of operations · EX-99.2 to Form 8-K
Shoulder Innovations Reports Second Quarter 2025 Financial Results
Results of operations · EX-99.1 to Form 8-K